Vaccines
Oxford undertakes world-leading vaccine research
The development of vaccines for the treatment or prevention of disease is a major strength at Oxford.
Active research programmes for the study of TB, malaria, HIV, HCV, HBV, Ebola virus, Zika virus and several childhood diseases such as meningococcal disease are ongoing.
DEPARTMENTS IN THIS THEME
- Nuffield Department of Clinical Medicine
- Department of Paediatrics
- Radcliffe Department of Medicine
- Sir William Dunn School of Pathology
- Department of Biochemistry
Recent publications
Click here to view recent publications from this theme
LINKED THEMES
|
|
|
|
|
|
|
|
|
|
|
|
People in this Theme
-
Adrian Hill
Director of the Jenner Institute and Wellcome Trust Senior Investigator, Professor of Human Genetics and NIHR Senior Investigator
-
Helen McShane
Director of the Oxford NIHR Biomedical Research Centre; Professor of Vaccinology at Oxford University; Deputy Head (Translation and Personnel), Medical Sciences Division; and an Honorary Consultant Physician in Infectious Diseases
-
Sir Andrew Pollard
Ashall Professor of Infection & Immunity
-
Gavin Screaton
Head of Medical Sciences Division
-
Graham Ogg
Professor of Dermatology
-
Persephone Borrow
Professor of Viral Immunology
-
Andrew McMichael
Professor of Molecular Medicine and Group Head / PI
-
Ellie Barnes
Professor of Hepatology and Experimental Medicine
-
John Frater
Professor of Infectious Diseases
-
Sarah Gilbert
Professor of Vaccinology
-
Simon Draper
Wellcome Trust Senior Fellow
-
Arturo Reyes-Sandoval
Associate Professor
-
Thomas Bowden
Associate Professor
-
Peter Simmonds
Professor of Virology
-
Sumi Biswas
Associate Professor
-
Alexander (Sandy) Douglas
Research Group Leader
-
Teresa Lambe
Professor (OBE)
-
Nicola Ternette
Senior Scientist
